CDNA CareDx Inc
Price (delayed)
$17.64
Market cap
$977.71M
P/E Ratio
17.64
Dividend/share
N/A
EPS
$1
Enterprise value
$884.7M
CareDx, Inc., headquartered in South San Francisco, California, is a leading precision medicine solutions company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant
Highlights
CareDx's EPS has soared by 137% from the previous quarter and by 128% YoY
CareDx's net income has soared by 137% from the previous quarter and by 128% YoY
The company's quick ratio fell by 3.4% QoQ
Key stats
What are the main financial stats of CDNA
Market
Valuations
Earnings
Shares outstanding
55.43M
Market cap
$977.71M
Enterprise value
$884.7M
Price to earnings (P/E)
17.64
Price to book (P/B)
2.5
Price to sales (P/S)
2.79
EV/EBIT
21.53
EV/EBITDA
14.54
EV/Sales
2.65
Revenue
$333.79M
Gross profit
$224.16M
Operating income
$40.77M
Net income
$52.55M
EBIT
$41.09M
EBITDA
$60.85M
Free cash flow
$31.56M
Per share
Balance sheet
Liquidity
EPS
$1
EPS diluted
$0.93
Free cash flow per share
$0.6
Book value per share
$7.06
Revenue per share
$6.32
TBVPS
$7.82
Total assets
$491.05M
Total liabilities
$112.62M
Debt
$22.26M
Equity
$378.43M
Working capital
$262.46M
Debt to equity
0.06
Current ratio
3.94
Quick ratio
3.65
Net debt/EBITDA
-1.53
Margins
Efficiency
Dividend
EBITDA margin
18.2%
Gross margin
67.2%
Net margin
15.7%
Operating margin
12.2%
Return on assets
11.1%
Return on equity
17.9%
Return on invested capital
17.5%
Return on capital employed
10.2%
Return on sales
12.3%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
CDNA stock price
How has the CareDx stock price performed over time
Intraday
-6.77%
1 week
-6.67%
1 month
-28.99%
1 year
67.52%
YTD
-17.61%
QTD
-17.61%
Financial performance
How have CareDx's revenue and profit performed over time
Revenue
$333.79M
Gross profit
$224.16M
Operating income
$40.77M
Net income
$52.55M
Gross margin
67.2%
Net margin
15.7%
CareDx's net income has soared by 137% from the previous quarter and by 128% YoY
The net margin has surged by 134% since the previous quarter and by 123% year-on-year
The operating income has surged by 126% since the previous quarter and by 120% year-on-year
CareDx's operating margin has soared by 124% from the previous quarter and by 117% YoY
Growth
What is CareDx's growth rate over time
Valuation
What is CareDx stock price valuation
P/E
17.64
P/B
2.5
P/S
2.79
EV/EBIT
21.53
EV/EBITDA
14.54
EV/Sales
2.65
CareDx's EPS has soared by 137% from the previous quarter and by 128% YoY
The stock's price to book (P/B) is 47% less than its 5-year quarterly average of 4.7 and 31% less than its last 4 quarters average of 3.6
The equity has increased by 45% YoY and by 38% from the previous quarter
The price to sales (P/S) is 59% less than the 5-year quarterly average of 6.8 and 15% less than the last 4 quarters average of 3.3
The revenue has increased by 19% YoY and by 7% QoQ
Efficiency
How efficient is CareDx business performance
CDNA's return on assets has surged by 136% since the previous quarter and by 129% year-on-year
The ROE has soared by 135% YoY and by 133% from the previous quarter
The ROIC has soared by 127% QoQ and by 125% YoY
CareDx's ROS has soared by 125% from the previous quarter and by 117% YoY
Dividends
What is CDNA's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for CDNA.
Financial health
How did CareDx financials performed over time
CareDx's total liabilities has decreased by 45% YoY and by 45% from the previous quarter
The company's total assets rose by 5% YoY and by 2.9% QoQ
The debt is 94% smaller than the equity
The equity has increased by 45% YoY and by 38% from the previous quarter
CareDx's debt to equity has decreased by 45% YoY and by 33% QoQ
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.